Drug Shortages Leave Healthcare Providers Foraging for Vital Medicines
Unprofitable Drugs…
The Star Ledger Sunday Business Section recently printed a front page article called, “Shortage puts lives in Jeopardy: Cancer drugs’ scarcity a persistent problem” by Susan Todd. Todd highlights that in New Jersey there is a notable shortage of some cancer treatment drugs. These shortages began to show up about four years ago. The cause seems to be manufacturing problem, supplies of ingredients, or ceasing to make unprofitable drugs. Profitability is argued as the key reason.
What is notable is that New Jersey is the drug company state. Most major drug companies are headquartered in New Jersey. So the shortage here is very notable.
What is the take away relative to ethics? Regulation and other factors that increase costs may limit supplies. Yes, this is basic economics, but it is also the law of business. Business has to make a profit to remain in business. Governments and NGOs do not. When the government intrudes it brings in the profit not essential orientation.
That the U.S. has drug shortages should be a wake-up call on the environment for business and the resulting quality of life. It must be pointed out that the wonderful progress in living standards over the past 200 years is mostly due to innovative businesses. We should understand that even as a community can go forward, it can also go backward. A great example is the City of Detroit and the decay of the past 50 years.


